Searched for
ISRAELI DRUG MAKER
Weight is over! Pharma companies race to make weight-loss drug semaglutideIndian drugmakers, including Dr. Reddy's and Zydus Lifesciences, are investing heavily in manufacturing capabilities to launch generic vers...
Glenmark to pay $30 million in an antitrust settlement in US over cholesterol drug pricingThe company in an exchange notification said that it has entered into a three-year deferred prosecution agreement, and if the company adher...
Marksans Pharma acquires Teva's manufacturing site in GoaThe manufacturing site is spread across 47,597 sq meters and has approvals to manufacture products from EU, Health Canada and Japanese Heal...
Dr Reddy's gearing up to get substantial slice of Revlimid generic opportunity in USRevlimid is a top-selling cancer drug from Bristol Myers Squibb. Its generic form, called lenalidomide, is seen as Dr Reddy's most anticipa...
Submitted proposal to DCGI to test Sputnik Light as Covid booster dose: Dr Reddy's"As regards to Sputnik, we are now ready with capacities in India. We are working actively with the Government of India for registering Spu...
Dr Reddy's lines up Rs 1,000 crore capex for current fiscal yearThe Hyderabad based firm invested about Rs 1,000 crore in the 2020-21 fiscal year.
Dr Reddy's in talks with RDIF on Sputnik V for other countriesDr Reddy's which had received over two lakh vaccines from RDIF, recently soft-launched Sputnik V and tied up with Apollo Hospitals for pilo...
Aurobindo Pharma may buy Portugal's Generis, deal likely to be valued at $200 millionAurobindo's latest bid comes on the heels of last month’s shot at Israeli drug maker Teva's UK product portfolio, where it was outbid by ri...
Teva may move court against Dr Reddy's for patent infringementThe Israeli drug maker already is involved in various legal battles with other drug firms over the patent litigations of Copaxone.
Teva Pharmaceutical recalls 38,858 bottles of drugs made by Emcure Pharmaceuticals in US marketThe company is also recalling 7,694 bottles of anti- inflammatory drug indomethacin 25 mg, produced by Emcure Pharma, for non-adherence to ...
US Patents rejects Teva's plea on Copaxone; Natco shares upHyderabad-based Natco markets Copaxone (Glatiramer Acetate) -- used in the treatment of relapsing-remitting multiple sclerosis -- in the US...
Claris Lifesciences gets USFDA drug approvalClaris Lifesciences Ltd, a parenteral drug company has received drug approval from US drug authorities for hypertension and angina treatmen...
- Pharmaceutical companies should consider mergers: Dilip Shanghvi
Pharmaceutical companies, who are battling growing competition from each other and resurgent multinationals, may have to shake hands.
- Sun Pharma buys controlling stake in Taro, shares up
Sun Pharmaceuticals today said it has acquired a controlling stake in Israeli pharma major Taro Pharmaceuticals.
- Taro accuses Sun of waging proxy war
Israeli drug maker Taro Pharma has alleged that Sun Pharma is attempting to seize its control by waging a proxy war.
- Sun Pharma extends open offer to April 17, 2009
Sun Pharmaceutical Industries has extended the open offer for acquiring shares of Israeli drug maker Taro Pharmaceutical which was schedule...
- Sun Pharma extends open offer to April 3, 2009
Sun Pharmaceutical Industries has extended the open offer, which was to expire today, for acquiring shares of Israeli drug maker Taro Pharm...
- Sun Pharma extends Taro open offer till October 3
Drug maker Sun Pharmaceuticals open offer for purchase of all outstanding shares of Taro has been extended to October 3 with a possibility ...
- Indian drug makers eye US firm Par Pharma
India's top drug makers are in the race to acquire US-based generic drug maker, Par Pharmaceutical Co Inc, two Indian newspapers reported o...
- Sun may hike offer for Taro stake
Sun Pharmaceutical Industries, which has been struggling over the last few months to gain control over Israel’s Taro Pharmaceutical Industr...